| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | -59.1% |
| SG&A Expense | $4.3M | -41.9% |
| Operating Income | -$11.3M | +50.8% |
| Interest Expense | -$93K | -232.1% |
| Net Income | -$10.8M | +52.0% |
| EPS (Basic) | -$2.86 | -340.0% |
| EPS (Diluted) | -$2.86 | -340.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | +35.9% |
| Current Assets | $5.0M | +38.6% |
| Total Assets | $5.7M | +25.7% |
| Current Liabilities | $7.0M | -39.0% |
| Stockholders' Equity | -$19.6M | -8.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | +39.4% |
| Capital Expenditures | $74K | +0.0% |
| Investing Cash Flow | -$74K | +0.0% |
| Financing Cash Flow | $10.8M | +2757.3% |
| Free Cash Flow | -$9.6M | +39.2% |